The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

被引：4
|
作者：
Han, Ji Whan [1 ]
机构：
[1] Catholic Univ Korea, Dept Pediat, Yeouido St Marys Hosp, Coll Med, 10,63-Ro, Seoul 07345, South Korea
来源：
KOREAN CIRCULATION JOURNAL | 2017年 / 47卷 / 02期
关键词：
GAMMA-GLOBULIN; THERAPY; MODULATE; SYSTEM;
D O I：
10.4070/kcj.2017.0011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：179 / 181
页数：3
相关论文
共 50 条
  • [31] Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children
    Shu Wu
    Ying Liao
    Yan Sun
    Chun-Yu Zhang
    Qing-You Zhang
    Hui Yan
    Jian-Guang Qi
    Xue-Qin Liu
    Yong-Hong Chen
    Yu-Li Wang
    Xue-Ying Li
    Hong-Fang Jin
    Jun-Bao Du
    World Journal of Pediatrics, 2020, 16 : 607 - 613
  • [32] Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease
    Lee, KY
    Han, JW
    Lee, JS
    Whang, KT
    ACTA PAEDIATRICA, 2002, 91 (02) : 164 - 167
  • [33] Single high-dose intravenous immunoglobulin therapy for Kawasaki disease increases plasma viscosity
    Baba, R
    Shibata, A
    Tsurusawa, M
    CIRCULATION JOURNAL, 2005, 69 (08) : 962 - 964
  • [34] High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease
    Nolan, Brian E.
    Wang, Yunfei
    Pary, Philippe P.
    Luban, Naomi L. C.
    Wong, Edward C. C.
    Ronis, Tova
    TRANSFUSION, 2018, 58 (11) : 2564 - 2571
  • [35] Comparison of high-dose and low dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome
    Saulsbury, FT
    CLINICAL PEDIATRICS, 2002, 41 (08) : 597 - 601
  • [36] Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial
    Fukui, Saori
    Seki, Mitsuru
    Minami, Takaomi
    Kotani, Kazuhiko
    Oka, Kensuke
    Yokomizo, Akiko
    Matsubara, Daisuke
    Sato, Tomoyuki
    Nozaki, Yasuyuki
    Saito, Mari
    Kikuchi, Yutaka
    Miyamoto, Kenji
    Monden, Yukifumi
    Yamagata, Takanori
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [37] Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial
    Saori Fukui
    Mitsuru Seki
    Takaomi Minami
    Kazuhiko Kotani
    Kensuke Oka
    Akiko Yokomizo
    Daisuke Matsubara
    Tomoyuki Sato
    Yasuyuki Nozaki
    Mari Saito
    Yutaka Kikuchi
    Kenji Miyamoto
    Yukifumi Monden
    Takanori Yamagata
    Pediatric Rheumatology, 19
  • [38] Predictive modeling of consecutive intravenous immunoglobulin treatment resistance in Kawasaki disease: A nationwide study
    Cheon, Eun Jung
    Kim, Gi Beom
    Park, Seung
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [39] Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease
    Matsuguma, C.
    Wakiguchi, H.
    Suzuki, Y.
    Okada, S.
    Furuta, T.
    Ohnishi, Y.
    Azuma, Y.
    Ohga, S.
    Hasegawa, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2019, 48 (06) : 491 - 496
  • [40] High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more
    Takanori Suzuki
    Nobuaki Michihata
    Tetsushi Yoshikawa
    Tadayoshi Hata
    Hiroki Matsui
    Kiyohide Fushimi
    Hideo Yasunaga
    European Journal of Pediatrics, 2020, 179 : 1901 - 1907
12345